Guidant Agrees With OIG To Educate Employees, Promote Reporting
This article was originally published in The Gray Sheet
Executive Summary
Guidant will sidestep the more onerous requirements of its 1Corporate Integrity Agreement with HHS by dissolving its EVT division this fall
You may also be interested in...
Senate Probes Guidant’s Compliance With Its Corporate Integrity Agreement
Senate Finance Committee Chair Chuck Grassley (R-Iowa) is investigating the recent series of Guidant device recalls to determine if the company violated the terms of its 2003 Corporate Integrity Agreement (CIA)
Senate Probes Guidant’s Compliance With Its Corporate Integrity Agreement
Senate Finance Committee Chair Chuck Grassley (R-Iowa) is investigating the recent series of Guidant device recalls to determine if the company violated the terms of its 2003 Corporate Integrity Agreement (CIA)
Business Effectiveness Cited As Key Component Of Compliance Programs
Business considerations are as important as legal requirements for effective compliance programs, TAP Pharmaceutical Products VP and Ethics & Compliance Officer Stephan Vincze said Sept. 14 at a Food & Drug Law Institute meeting in Washington, D.C